Researchers study young cancer survivors and their opioid use.
Young cancer survivors were more likely to be on long-term opioid therapy when compared to their counterparts without cancer. But among those on long-term opioid therapy, young cancer survivors were less likely to develop opioid use disorder than their peers without cancer, according to Kaiser Permanente ...
Featured News
Algorithm improves MS treatment while reducing disparities
A novel treatment algorithm developed and implemented within Kaiser Permanente Southern California increased the use of effective medications for people with multiple sclerosis (MS), and reduced treatment ...
Five questions for … Dr. Navdeep Sangha
Navdeep S. Sangha, MD, is a vascular neurologist and co-assistant chief of Neurology at the Kaiser Permanente Los Angeles Medical Center. He is the director of the Kaiser Permanente Southern California ...
Clinical trials nurse brings skill and compassion to patients in San Diego
*Final in a series highlighting research nurses during Nurses Week 2025* Michael Fechter, LVN, was an emergency medical technician, working to become a paramedic and firefighter. On one emergency call, ...
COVID-19 vaccine trials for children are underway
July 30, 2021When their parents asked if they wanted to be part of a COVID-19 vaccine trial for children, Aidan and Avery Shih didn’t have to think about it for long. Both were eager to help end the pandemic. “The vaccine does help you not get COVID, of course, but then also it helps you so you don't spread COVID. So, if enough people get the vaccine, COVID will slow and hopefully eventually stop,” said Aidan, 11.Read more...New protocol allows teen to go home same day as chest surgery
July 27, 2021About 5 years ago, John Connell, now 16, was at a water park when a friend pointed his index finger at John’s bare chest and asked, “Were you in a car accident or something?” John looked down at his chest, and then at the chests of the other boys around him, and realized for the first ...Read more...Risk of blood clots more than 3-fold higher in hospitalized adults with COVID-19
July 23, 2021Hospitalized adults who have COVID-19 are more than 3 times as likely to develop a blood clot than adults who do not have COVID-19, according to new research from Kaiser Permanente Southern California and Kaiser Permanente Northern California. The study published July 20 in CHEST found Black patients as well as patients who had obesity, liver ...Read more...5 questions for … Dr. Erin Hahn
June 28, 2021Erin E. Hahn, PHD, MPH, is a health services researcher and implementation scientist. Her primary research interests are quality of care in oncology and the implementation of evidence-informed practices. She is particularly interested in the care of cancer survivors after their initial cancer treatment. Dr. Hahn joined the Department of Research & Evaluation as the ...Read more...Rates of heart failure deaths lower at Kaiser Permanente Southern California than U.S.
June 28, 2021A Kaiser Permanente Southern California research study found lower rates of heart failure mortality within the integrated health care system compared to the country as a whole. “In our study, we analyzed the overall rates of death attributable to heart failure throughout the state of California and United States, and then compared that to what we ...Read more...Kaiser Permanente Los Angeles Medical Center joins COVID-19 vaccine trial for children
June 11, 2021Kaiser Permanente Los Angeles Medical Center is participating in a clinical trial for the Moderna COVID-19 vaccine in children ages 6 months to less than 12 years. The KidCOVE study will evaluate the safety and efficacy of the Moderna COVID-19 vaccine (mRNA-1273), which is the same vaccine that was given Emergency Use Authorization (EUA) in December ...Read more...Kaiser Permanente Los Angeles Medical Center to study experimental stroke drug
June 4, 2021Kaiser Permanente Los Angeles Medical Center will conduct a multi-centered, randomized, Phase 3 research study to learn if the experimental drug recombinant Factor VIIa (rFVIIA), a protein that our body makes, can be used to decrease bleeding in the brain of patients who suffer sudden bleeding in the brain, also called intracerebral hemorrhage. The study entitled ...Read more...Marking Clinical Trials Day 2021 with gratitude
May 20, 2021On this day—May 20, 2021, aka Clinical Trials Day—we have more reasons than ever to celebrate the Kaiser Permanente Southern California clinical trials team. We began our COVID-19 clinical trials research with the remdesivir trial in March 2020. We were a top enroller in that study. Since then, our clinical trials program has participated in 9 ...Read more...Kaiser Permanente members have higher survival rate after cancer diagnosis
May 14, 2021Among insured cancer patients in Southern California, those who were diagnosed and treated at Kaiser Permanente, an integrated health care organization, had better survival rates, especially Black and Latinx patients, according to Kaiser Permanente research published in The American Journal of Managed Care. “Kaiser Permanente is committed to finding and addressing health care inequities,” said the ...Read more...COVID-19 outcomes are more severe for people of color
May 4, 2021A new Kaiser Permanente study published in Annals of Internal Medicine found that people of color were more likely to be hospitalized and to receive intensive-level care for COVID-19 compared to white patients even after adjusting for known health risk factors such as obesity, diabetes, and other conditions The study was among the first to show that these ...Read more...